We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
6.4 quarters
Top 10 Avg Time Held
4.4 quarters
Top 20 Avg Time Held
3.3 quarters

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MON
51
DELISTED
Monsanto Co
MON
$37.9M 0.76%
431,938
+44,447
+11% +$4.01M
2013 Q2
11 quarters
BX icon
52
Blackstone
BX
$80.7B
$37.2M 0.75%
1,324,610
-61,446
-4% -$1.62M
2014 Q2
7 quarters
CMG icon
53
Chipotle Mexican Grill
CMG
$37.9B
$36.9M 0.74%
3,912,750
-4,417,100
-53% -$42M
2013 Q2
11 quarters
ABBV icon
54
AbbVie
ABBV
$498B
$35.5M 0.71%
621,238
+1,289
+0.2% +$71.8K
2013 Q2
11 quarters
WHR icon
55
Whirlpool
WHR
$1.82B
$34.9M 0.7%
193,649
-3,931
-2% -$586K
2013 Q2
11 quarters
VTR icon
56
Ventas
VTR
$42.8B
$32.6M 0.65%
+517,036
New +$29.1M
2016 Q1
0 quarters
AYI icon
57
Acuity Brands
AYI
$8.93B
$31.7M 0.64%
145,224
+50,721
+54% +$10.5M
2015 Q1
4 quarters
EPD icon
58
Enterprise Products Partners
EPD
$77.5B
$29.2M 0.59%
1,186,024
+8,423
+0.7% +$196K
2013 Q2
11 quarters
SABR icon
59
Sabre
SABR
$726M
$26.9M 0.54%
930,174
+472,794
+103% +$12.6M
2015 Q1
4 quarters
BIP icon
60
Brookfield Infrastructure Partners
BIP
$16.5B
$26.5M 0.53%
1,582,477
+499,484
+46% +$7.25M
2013 Q2
11 quarters
BLK icon
61
Blackrock
BLK
$169B
$25.9M 0.52%
75,987
-5,242
-6% -$1.66M
2013 Q2
11 quarters
ARMH icon
62
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$25.7M 0.52%
587,792
-81,340
-12% -$3.4M
2013 Q2
11 quarters
REGN icon
63
Regeneron Pharmaceuticals
REGN
$79B
$25.5M 0.51%
70,802
-78,950
-53% -$32.5M
2013 Q3
10 quarters
CTSH icon
64
Cognizant
CTSH
$28.2B
$24.9M 0.5%
396,499
-18,405
-4% -$1.07M
2013 Q2
11 quarters
CAH icon
65
Cardinal Health
CAH
$56.4B
$22.5M 0.45%
274,150
-282,570
-51% -$23M
2014 Q1
8 quarters
AVY icon
66
Avery Dennison
AVY
$12.9B
$22.2M 0.45%
308,107
+302,424
+5,322% +$19.6M
2013 Q3
10 quarters
SIX icon
67
DELISTED
Six Flags Entertainment Corp.
SIX
$19.4M 0.39%
348,971
+107,196
+44% +$5.52M
2015 Q4
1 quarter
FRC
68
DELISTED
First Republic Bank
FRC
$17.6M 0.35%
263,364
-28,401
-10% -$1.82M
2013 Q2
11 quarters
WP
69
DELISTED
Worldpay, Inc.
WP
$17.3M 0.35%
+320,491
New +$15.7M
2016 Q1
0 quarters
BBWI icon
70
Bath & Body Works
BBWI
$3.7B
$17.1M 0.34%
+240,908
New +$17.3M
2016 Q1
0 quarters
V icon
71
Visa
V
$739B
$17M 0.34%
221,767
-19,043
-8% -$1.38M
2013 Q2
11 quarters
EQIX icon
72
Equinix
EQIX
$99.2B
$16.7M 0.34%
+50,575
New +$15.4M
2016 Q1
0 quarters
RHI icon
73
Robert Half
RHI
$3.52B
$15.3M 0.31%
328,476
-59,747
-15% -$2.5M
2013 Q2
11 quarters
BRK.B icon
74
Berkshire Hathaway Class B
BRK.B
$1.11T
$14.2M 0.29%
99,979
+16,372
+20% +$2.17M
2013 Q2
11 quarters
BFAM icon
75
Bright Horizons
BFAM
$3.31B
$13.9M 0.28%
214,982
+164,542
+326% +$10.6M
2014 Q3
6 quarters

Similar funds

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.